Imaging Approaches in Prostate Cancer

Clinical Pearls I

Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, describes imaging approaches in prostate cancer.

• Sodium fluoride PET represents a sensitive way of detecting bone metastases
• Sodium fluoride PET is reasonable to use before treatment with enzalutamide, sipuleucel-T, or abiraterone, in patients with rising PSA and negative conventional imaging

Clinical Pearls II

• The Artemis device is being looked at in clinical studies to help detect prostate cancer in localized biopsies
• Sodium acetate PET and amino acid imaging are still under investigation
• Petrylak is interested in research into imaging for targeted therapies to check for activity and eligibility